Metabolic and Proteomic Profiling of Coronary Microvascular Dysfunction: Insights from Rat Models
Biomolecules · 2024
DOI: 10.3390/biom14101305 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Yan Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cardiovascular Diseases, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China. Hauptthemen laut MEDLINE: Proteomics, Rats, Wistar. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: WeihongCong, Qiqi Xin, XYZX0304-07.
Abstract (Originalsprache)
Coronary microvascular dysfunction (CMD) represents a principal etiological factor in ischemic heart disease. Nonetheless, a considerable subset of CMD patients experiences diagnostic delays attributable to the inadequacy of current diagnostic methodologies; which in turn results in deferred therapeutic interventions and elevated mortality rates. This study seeks to elucidate the distinct metabolic profile associated with CMD in rat models and to identify specific diagnostic markers that could enhance the diagnostic accuracy for CMD. In this study, 18 Wistar rats were randomly allocated into two groups: the sham group and the CMD group. The CMD group received injections of embolic microspheres into the left ventricle to establish a CMD model. Subsequently, non-targeted metabolomics and acetylated proteomics analyses were conducted. Machine-learning techniques were employed to identify the co-diagnostic markers of the disease. This study identified 53 key proteins through differential expression proteins (DEPs) and modular proteins analysis. Subsequently, four core proteins (Emc1; Ank1; Fbln2; and Hp) were determined as diagnostic markers for CMD using lasso regression, support vector machine, and random forest methodologies. Receiver operating characteristic curve analysis further demonstrated robust diagnostic performance. Gene ontology and kyoto encyclopedia of genes and genome enrichment analyses indicated that the DEPs were predominantly associated with metabolic pathways. Ultimately, the integrative analysis of proteomics and metabolomics suggested that the central metabolic mechanism underlying CMD pathogenesis may be linked to the tricarboxylic acid cycle. This study revealed specific changes in the proteomic and metabolic profiles of CMD rats and identified four diagnostic markers, which are proteins and metabolites that could be potential diagnostic biomarkers for CMD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Cardiovascular Diseases, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China.
- National Clinical Research Center for Chinese Medicine Cardiology, Beijing 100091, China.
- Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China.
ORCID-Profile: Yan Lu
Förderung
- WeihongCong
- Qiqi Xin
- XYZX0304-07
- Rongyuan
- CACMS Innovation Fund
- Irma and Paul Milstein Program for Senior Health of Milstein Medical Asian American Partnership Foundation
- Beijing Novaprogram
- Hospital Capability Enhancement Project of Xiyuan Hospital
Zitieren
APA
Lu, Y., Wang, Y., Xin, Q., Yuan, R., Chen, K., Chu, J., & Cong, W. (2024). Metabolic and Proteomic Profiling of Coronary Microvascular Dysfunction: Insights from Rat Models. Biomolecules. https://doi.org/10.3390/biom14101305
Vancouver
Lu Y, Wang Y, Xin Q, Yuan R, Chen K, Chu J, et al. Metabolic and Proteomic Profiling of Coronary Microvascular Dysfunction: Insights from Rat Models. Biomolecules. 2024. doi:10.3390/biom14101305
BibTeX
@article{Lu2024,
author = {Lu, Yan and Wang, Yuying and Xin, Qiqi and Yuan, Rong and Chen, Keji and Chu, Jianfeng and Cong, Weihong},
title = {Metabolic and Proteomic Profiling of Coronary Microvascular Dysfunction: Insights from Rat Models},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14101305}
}
EUVIMED